On August 31, 2023 Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company (the "Company"), reported that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of the Company at the hybrid H.C. Wainwright 25th Annual Global Investment Conference, which will be held September 11-13, 2023 (Press release, Puma Biotechnology, AUG 31, 2023, View Source [SID1234634820]). The virtual presentation will be available on demand beginning at 7:00 a.m. EDT on September 11, 2023 on the Company’s website at View Source for 30 days following the presentation.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!